跳至主要内容
临床试验/NCT02744508
NCT02744508已完成不适用

Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 202 人开始时间: 2015年7月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
202
试验地点
1
主要终点
incidence of clinically significant PONV with PONV impact scale

研究概览

简要总结

Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who are undergoing minor orthopedic surgery.
  • IV patient controlled analgesia

排除标准

  • minority (0~19 year)
  • patients who are belongs to ASA class 3 or more, and have underlying complicated cardiovascular or psychological disease.
  • Steroid medication
  • Diabetes Mellitus medication

研究组 & 干预措施

P group

Active Comparator

Palonosetron group

干预措施: palonosetron (Drug)

PD group

Experimental

Palonosetron and dexamethasone group

干预措施: palonosetron with dexamethasone (Drug)

结局指标

主要结局

incidence of clinically significant PONV with PONV impact scale

时间窗: 72 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison of Palonosetron Versus Combination of... | 临床试验